Published in Antimicrob Agents Chemother on March 01, 1980
The effects of a series of prostaglandins on in vitro models of the allergic response and cellular immunity. Prostaglandins (1972) 1.67
Regulation of macrophage tumoricidal function: a role for prostaglandins of the E series. Science (1978) 1.51
The regulation of the immune response to T-independent antigens by prostaglandins and B cells. J Immunol (1976) 1.40
ANTIVIRAL CHEMOTHERAPEUTIC ASSAY WITH FRIEND LEUKEMIA VIRUS IN MICE. Cancer Chemother Rep (1965) 1.39
Suppressed response to interferon inducation in mice infected with encephalomyocarditis virus, Semliki forest virus, influenza A2 virus, Herpesvirus hominis type 2, or murine cytomegalovirus. J Infect Dis (1977) 1.32
Enhancement of natural and antibody-dependent lymphocyte cytotoxicity by drugs which inhibit prostaglandin production by tumor target cells. Cell Immunol (1978) 1.27
Functional and morphologic characteristics of interferon-treated macrophages. Cell Immunol (1978) 1.23
Interferon inducers in therapy of infection with encephalomyocarditis virus in mice. I. Effect of single doses of polyriboinosinic-polyribocytidylic acid and tilorone hydrochloride on viral pathogenesis. J Infect Dis (1974) 1.14
Prostaglandin restoration of the interferon response of hyporeactive animals. Science (1978) 1.03
Initial clinical trials in cancer patients of polyriboinosinic-polyribocytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly(ICLC)], a highly effective interferon inducer. Cancer Res (1979) 1.01
Murine leukemia: depressed response to interferon induction correlated with a serum hyporeactive factor. Infect Immun (1976) 0.94
Didemnins: antiviral and antitumor depsipeptides from a caribbean tunicate. Science (1981) 1.90
Suppressed response to interferon inducation in mice infected with encephalomyocarditis virus, Semliki forest virus, influenza A2 virus, Herpesvirus hominis type 2, or murine cytomegalovirus. J Infect Dis (1977) 1.32
Tilorone hydrochloride: an oral interferon-inducing agent. Antimicrob Agents Chemother (1972) 1.28
Hyporeactivity of infection: potential limitation to therapeutic use of interferon-inducing agents. Infect Immun (1972) 1.23
Interferon inducers in therapy of infection with encephalomyocarditis virus in mice. I. Effect of single doses of polyriboinosinic-polyribocytidylic acid and tilorone hydrochloride on viral pathogenesis. J Infect Dis (1974) 1.14
Virus and interferon effects on cellular prostaglandin biosynthesis. J Immunol (1980) 1.12
Hyporeactivity due to infection: recognition of a transferable hyporeactive factor in the serum of encephalomyocarditis virus-infected mice. Infect Immun (1974) 1.04
Prostaglandin restoration of the interferon response of hyporeactive animals. Science (1978) 1.03
Hyporeactivity to interferon induction: characterization of a hyporeactive factor in the serum of encephalomyocarditis virus-infected mice. Infect Immun (1975) 1.00
Prostaglandin D2 formation by malignant melanoma cells correlates inversely with cellular metastatic potential. Proc Natl Acad Sci U S A (1979) 0.95
Antiviral and interferon-inducing properties of 1,5-diamino anthraquinones. Antimicrob Agents Chemother (1979) 0.94
Murine leukemia: depressed response to interferon induction correlated with a serum hyporeactive factor. Infect Immun (1976) 0.94
Interferon induction by 5-halo-6-phenyl pyrimidinones. J Interferon Res (1980) 0.94
Comparation interferon- inducing and antiviral properties of 2-amino-5-bromo-6-methyl-4-pyrimidinol (U-25,166), tilorone hydrochloride, and polyinosinic-polycytidylic acid. Antimicrob Agents Chemother (1977) 0.92
Interferon inducers in therapy of infection with encephalomyocarditis virus in mice. II. Effect of multiple doses of polyriboinosinic-polyribocytidylic acid on viral pathogenesis. J Infect Dis (1974) 0.90
5-substituted 2-amino-6-phenyl-4(3H)-pyrimidinones. Antiviral- and interferon-inducing agents. J Med Chem (1980) 0.88
5-halo-6-phenyl pyrimidinones: new molecules with cancer therapeutic potential and interferon-inducing capacity are strong inducers of murine natural killer cells. J Immunol (1983) 0.87
Inhibitors of topoisomerase II: structure-activity relationships and mechanism of action of podophyllin congeners. Adv Enzyme Regul (1988) 0.87
Validation of a reverse transcription nested polymerase chain reaction (RT-nPCR) to detect bovine viral diarrhea virus (BVDV) associated with in vitro-derived bovine embryos and co-cultured cells. Theriogenology (2001) 0.86
Replication and persistence of different strains of bovine viral diarrhea virus in an in vitro embryo production system. Theriogenology (2000) 0.86
Studies on the antitumor activities of pyrimidinone-interferon inducers. I. Effect against artificial and spontaneous lung metastases of murine tumors. J Natl Cancer Inst (1982) 0.85
Bovine viral diarrhea virus (BVDV): epidemiologic concerns relative to semen and embryos. Theriogenology (2007) 0.84
Stimulation of natural killer cells in two random-bred strains of athymic rats by interferon-inducing pyrimidinone. J Immunol (1984) 0.84
Adherence of Haemophilus somnus to bovine embryos after in vitro exposure. Am J Vet Res (1988) 0.84
Pyrimidinones. 1. 2-Amino-5-halo-6-aryl-4(3H)-pyrimidinones. Interferon-inducing antiviral agents. J Med Chem (1985) 0.82
A microtitre cytotoxicity assay useful for the discovery of fermentation-derived antitumor agents. Cancer Chemother Pharmacol (1985) 0.82
Studies on the antitumor activities of pyrimidinone-interferon inducers. Part 2. Potentiation of antitumor resistance mechanisms. Clin Exp Metastasis (1986) 0.81
Comparison between circulating interferon and drug levels following administration of 2-amino-5-bromo-6-phenyl-4(3H)-pyrimidinone (ABPP) to different animal species. J Interferon Res (1982) 0.81
Prostaglandin D2 controls pulmonary metastasis of malignant melanoma cells. Nature (1979) 0.81
Necrotic oophoritis in heifers vaccinated intravenously with infectious bovine rhinotracheitis virus vaccine during estrus. Am J Vet Res (1990) 0.80
Development of a DNA probe for identification of bovine herpesvirus 4. Am J Vet Res (1993) 0.80
Phase I study of 2-amino-5-bromo-6-phenyl-4(3H)-pyrimidinone (ABPP), an oral interferon inducer, in cancer patients. J Biol Response Mod (1986) 0.80
Feline interferon response to 2-amino-5-bromo-6-methyl-4-pyrimidinol (U-25,166). Am J Vet Res (1977) 0.79
Glass capillary gas chromatography with electron-capture detection. Separation of prostaglandins. J Chromatogr (1979) 0.79
In vitro exposure of preimplantation bovine embryos to vesicular stomatitis virus. J Clin Microbiol (1986) 0.79
Analytical sensitivity of assays used for detection of bovine viral diarrhea virus in semen samples from the Southeastern United States. Vet Microbiol (2003) 0.79
A caudal flank approach for the collection of oviductal-stage bovine embryos. Theriogenology (1990) 0.78
Didemnins A and B. Effectiveness against cutaneous herpes simplex virus in mice. Antiviral Res (1983) 0.78
Bovine brucellosis: an investigation of latency in progeny of culture-positive cows. J Am Vet Med Assoc (1988) 0.78
Can antibody responses in cattle vaccinated with a multivalent leptospiral bacterin interfere with serologic diagnosis of disease? J Am Vet Med Assoc (1983) 0.78
Effects of aromatic cationic molecules on bovine viral diarrhea virus and embryonic development. Theriogenology (2005) 0.78
The effect of infectious bovine rhinotracheitis vaccine on reproductive efficiency in cattle vaccinated during estrus. Theriogenology (1990) 0.77
Prostacyclin biosynthesis in activated, stimulated and normal mouse peritoneal cell populations. Prostaglandins (1978) 0.77
Mitogenic activity in ovine uterine fluids: characterization of a growth factor activity which specifically stimulates myoblast proliferation. Biochem Biophys Res Commun (1988) 0.77
Efficacy of a recombinant trypsin product against bovine herpesvirus 1 associated with in vivo- and in vitro-derived bovine embryos. Theriogenology (2008) 0.76
Antiproliferative action of interferon on murine L1210 cells: interrelationship with prostaglandins. J Interferon Res (1983) 0.76
Interferon induction: hyporesponsiveness and prostaglandins. Tex Rep Biol Med (1983) 0.76
The effects of FSH-priming and dominant follicular regression on the superovulatory response of cattle. Theriogenology (1992) 0.76
Interferon induction by and toxicity of polyriboinosinic acid [poly(rI)].polyribocytidylic acid [poly (rC)], mismatched analog poly (rI).poly[r(C12Uracil)n], and poly(rI).poly(rC) L-lysine complexed with carboxymethylcellulose. Antimicrob Agents Chemother (1980) 0.75
Chemotherapy of viral infections. Arch Dermatol Res (1981) 0.75
Lactoferrin from bovine milk inhibits bovine herpesvirus 1 in cell culture but suppresses development of in vitro-produced bovine embryos. Anim Reprod Sci (2008) 0.75
Normal calves produced after transfer of in vitro fertilized embryos cultured with an antiviral compound. Theriogenology (2005) 0.75
Uterine tubal cells remain uninfected after culture with in vitro-produced embryos exposed to bovine viral diarrhea virus. Vet Microbiol (1999) 0.75
Analysis of natural killer cell activity in random-bred Rowett athymic rats. Exp Cell Biol (1984) 0.75
Resistance of preimplantation bovine embryos to infection with Brucella abortus. Am J Vet Res (1986) 0.75
Amplification of bovine viral diarrhoea virus introduced into an in vitro embryo production system via oocytes from persistently infected cattle. Reprod Domest Anim (2009) 0.75
Quantity and infectivity of embryo-associated bovine viral diarrhea virus and antiviral influence of a blastocyst impede in vitro infection of uterine tubal cells. Theriogenology (1999) 0.75
Health and Safety Advisory Committee (HASAC) of the International Embryo Transfer Society (IETS) has managed critical challenges for two decades. Theriogenology (2003) 0.75
Bovine viral diarrhea virus (BVDV) associated with single in vivo-derived and in vitro-produced preimplantation bovine embryos following artificial exposure. Theriogenology (2009) 0.75
Experimental antitumor activity of BMY-28175 a new fermentation derived antitumor agent. Invest New Drugs (1990) 0.75
Induction of interferon with low molecular weight compounds: fluorenone esters, ethers (tilorone), and pyrimidinones. Methods Enzymol (1981) 0.75
Prostaglandins and metastasis. Symp Fundam Cancer Res (1983) 0.75
Seroconversion of recipient ewes after transfer of ova exposed to Brucella ovis in vitro. Theriogenology (1990) 0.75
Adherence of Brucella ovis to preimplantation ovine ova. Theriogenology (1988) 0.75
Prostaglandin formation by murine malignant melanoma cells: inverse correlation with metastasis. Prog Lipid Res (1981) 0.75
Detection of bovine viral diarrhea virus (BVDV) in single or small groups of preimplantation bovine embryos. Theriogenology (2007) 0.75
Ecology of Western encephalitis virus. Proc Soc Exp Biol Med (1973) 0.75
In vitro exposure of ovine ova to (Brucella abortus ). Theriogenology (1989) 0.75
Production of the interferon protein: hyporesponsiveness. Tex Rep Biol Med (1977) 0.75
Chemically induced viral resistance in single preimplantation bovine embryos. Biochem Biophys Res Commun (1991) 0.75
Interferon inducers as antiviral agents. Compr Ther (1977) 0.75
Measurement of hyporesponsiveness to interferon and interferon induction with prostaglandins. Methods Enzymol (1986) 0.75
Detection of Brucella , abortus , in the cervical mucus of nulliparous heifers. Theriogenology (1986) 0.75
Interaction of Mycoplasma bovis and Mycoplasma bovigenitalium with preimplantation bovine embryos. Theriogenology (1989) 0.75
Antibiotic treatment of bovine embryos. J Assist Reprod Genet (1993) 0.75
Effects of hormone-induced superovulation on latent infectious bovine rhinotracheitis virus in cattle. Theriogenology (1989) 0.75
Effects of 5-halopyrimidinones with antiviral and antineoplastic activity on murine cytochrome P-450. J Biol Response Mod (1984) 0.75
Noncytopathic bovine viral diarrhea virus in a system for in vitro production of bovine embryos. Theriogenology (1994) 0.75
Antineoplastic properties of pyrimidinone interferon inducers. Adv Enzyme Regul (1980) 0.75
Overcoming mitomycin C resistance with semisynthetic derivatives. Prog Clin Biol Res (1986) 0.75